Papers
1
Total Citations
8
H-Index
1
About
Matthew Idle is a surgeon-scientist whose research focuses on advancing minimally invasive head and neck oncology, particularly through Transoral Robotic Surgery (TORS). His major contributions center on improving surgical outcomes for oropharyngeal cancer patients by integrating novel haemostatic technologies. In his landmark 2022 case series, Idle evaluated PuraBond®, a self-assembling topical haemostat that forms a transparent hydrogel matrix to control bleeding during TORS procedures. This work, which has garnered 8 citations, demonstrated how the technology enhances intraoperative visibility and reduces complications, directly addressing a critical challenge in robotic surgery. By systematically assessing PuraBond®'s efficacy in a clinical setting, Idle provided early evidence for its adoption in head and neck oncology, potentially reducing operative times and improving patient recovery. His research bridges the gap between surgical innovation and practical application, offering a safer, more efficient approach to treating oropharyngeal malignancies. Idle’s work is particularly notable for its translational impact, as it introduces a commercially available solution to a specialized surgical field, paving the way for larger trials and broader clinical implementation.
Research Focus
Key Achievements
Top Papers
- 1